Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Clinicopathological Analysis of "Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders" Reveals a Favorable Outcome Independent of the Effectiveness of Methotrexate Discontinuation in Autoimmune Disease Patients

Daisuke Kaji, MD, Manabu Kusakabe, MD PhD, Mamiko Sakata-Yanagimoto, MD PhD, Yasuhito Suehara, MD, Keiichiro Hattori, MD PhD, Yasunori Ota, MD PhD, Mitsuhiro Yuasa, MD, Kosei Kageyama, MD, Yuki Taya, MD PhD, Shinsuke Takagi, Hisashi Yamamoto, MD PhD, Yuki Asano-Mori, MD PhD, Naoyuki Uchida, MD PhD, Atsushi Wake, MD PhD, Shuichi Taniguchi, MD PhD, Go Yamamoto, MD PhD, Shigeru Chiba, MD PhD

Blood (2019) 134 (Supplement_1): 4128.

https://doi.org/10.1182/blood-2019-127521

Published: 2019

Journal Articles

Inflammatory Bowel Disease and Hodgkin's Lymphoma: Two New Observations

Zoubida Tazi Mezalek, MD, Myriam Bourkia, Sofia Habib Allah, Noha Al Waragli, Majdouline Bouaouad, Amina Lhoussni, MD, Hajar Khibri, Wafaa Ammouri, Mouna Maamar, Hicham Harmouche, Mohammed Adnaoui

Blood (2018) 132 (Supplement 1): 5353.

https://doi.org/10.1182/blood-2018-99-110615

Published: 2018

Journal Articles

Interferon May Help Control the Recurrence of Chronic Myeloid Leukemia after Discontinuation of Tyrosine Kinase Inhibitor

Jun Kong, MD, Xiao-Hong Liu, Ya-Zhen Qin, Hong-Xia Shi, Yue-Yun Lai, Xiao-Jun Huang, Hao Jiang

Blood (2018) 132 (Supplement 1): 4270.

https://doi.org/10.1182/blood-2018-99-119063

Published: 2018

Journal Articles

Maximum Tolerated Dose (MTD) and Safety Profile from Phase I Study of MT-3724 (CD20 targeted immunotoxin) in Relapsed/Refractory (R/R) Non-Hodgkin B-Cell Lymphoma (NHL)

Michelle A. Fanale, MD, Steven I. Park, MD, David J. Valacer, MD, Jack Higgins, PhD, John Mark Sloan, MD, Anas Younes, MD, Paul A. Hamlin, MD

Blood (2017) 130 (Supplement 1): 5212.

https://doi.org/10.1182/blood.V130.Suppl_1.5212.5212

Published: 2017

Journal Articles

Acetaminophen Caused Transfusion Dependent Children Repeated Hepatitis

Ching-Tien Peng, MD MPH, Chien-Yu Lin, Kang-Hsi Wu, Tefu Weng, Jan-Gowth Chang, Wan-Yu Lo

Blood (2017) 130 (Supplement 1): 4930.

https://doi.org/10.1182/blood.V130.Suppl_1.4930.4930

Published: 2017

Journal Articles

Long-Term Maintenance of Platelet Responses in Adult Patients with Persistent/Chronic Immune Thrombocytopenia Treated with Fostamatinib: 1-Year Efficacy and Safety Results

James B. Bussel, MD, Donald M Arnold, MD, Nichola Cooper, MA, MD MRCP, FRCPath, Alhossain A Khalafallah, MD, Michael Boxer, MD, Darla Liles, MD, Waleed Ghanima, MD PhD, Keith McCrae, MD, Hany Zayed, Benoit Cadieux, PhD, Anne-Marie Duliege, MDMS

Blood (2017) 130 (Supplement 1): 16.

https://doi.org/10.1182/blood.V130.Suppl_1.16.16

Published: 2017

Journal Articles

Avatrombopag, a Novel Oral Thrombopoietin Receptor Agonist, Demonstrates Superiority to Placebo for the Treatment of Chronic Immune Thrombocytopenic Purpura in a Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Wojciech Jurczak, PhDMD, Krzysztof Chojnowski, MD, Jiri Mayer, Prof, MD SCs, Katarzyna Krawczyk, MD PhD, Francesco Bibbiani, MD

Blood (2017) 130 (Supplement 1): 17.

https://doi.org/10.1182/blood.V130.Suppl_1.17.17

Published: 2017

Journal Articles

A Novel Dual Class III/Src Family Tyrosine Kinase Inhibitor Is Highly Active Against FLT3-ITD Leukemia Cells In Vivo

Tereza Radosova Muchova, Eva Reznickova, Zuzana Somikova, Tomas Gucky, Miroslav Strnad, DSc, Vladimir Krystof, PhD, Vladimir Divoky, PhD

Blood (2016) 128 (22): 1569.

https://doi.org/10.1182/blood.V128.22.1569.1569

Published: 2016

Journal Articles

Observational Study of Magnetic Resonance Imaging Monitoring in Patients with Aplastic Anemia (AA) and Low or Int-1 Risk of Myelodysplastic Syndromes(MDS) Complicated with Iron Overload

Yali Du, bachelor, Bing Han, MD, Zhangbiao Long, master, Miao Chen, master, Bo Hou, master, Feng Feng, MD, Zhao Wang, MD

Blood (2016) 128 (22): 4825.

https://doi.org/10.1182/blood.V128.22.4825.4825

Published: 2016

Journal Articles

Data from the First CD20-Targeted Immunotoxin, MT-3724, in a Phase I/Ib Study in Relapsed/Refractory (R/R) Non-Hodgkin's B-Cell Lymphoma (NHL)

Paul A Hamlin, Jr., MD, Michelle A. Fanale, MD, Steven I. Park, MD, David J. Valacer, MD, Jack Higgins, PhD, Anas Younes, MD

Blood (2016) 128 (22): 4200.

https://doi.org/10.1182/blood.V128.22.4200.4200

Published: 2016

Journal Articles

Thrombotic Microangiopathy in Multiple Myeloma

Jennifer Yui, MD, Jan Van Keer, MD, Ravi Vij, MD, Kenar Jhaveri, MD, Efstathios Kastritis, MD, Francis Buadi, MD, Angela Dispenzieri, MD, David Dingli, MD PhD FRCP, Stephen J. Russell, MD PhD, Nelson Leung, MD

Blood (2015) 126 (23): 5317.

https://doi.org/10.1182/blood.V126.23.5317.5317

Published: 2015

Journal Articles

Pulmonary Hypertension (PHT) and Pleural Effusion During Dasatinib Therapy For CML Frequently Lead To Drug Withdrawal

Maciek Tatarczuch, John F Seymour, MBBS, PhD, FRACP, Louise Creati, Elchanan H. Januszewicz, MBBS, Kate Burbury, MBBS, FRACP, FRCPA, DPhil

Blood (2013) 122 (21): 1504.

https://doi.org/10.1182/blood.V122.21.1504.1504

Published: 2013

Journal Articles

Quality of Life Post Hematopoietic Stem Cell Transplantation for Pediatric Acute Leukemia in Mainland China

Yanhui Luo, Xuan Zhou, Huyong Zheng, MD. PhD, Bin Wang, Maoquan Qin, Yuan Sun, MD, Aihua Wang, Ying Chang, Minyuan Wu, Yuesong Pan

Blood (2013) 122 (21): 5595.

https://doi.org/10.1182/blood.V122.21.5595.5595

Published: 2013

Journal Articles

Extended Exposure To The CXCR4 Inhibitor Plerixafor May Lead To Enhanced Microenvironment Interactions in Acute Lymphoblastic Leukemia (ALL)

Edward Allan R. Sison, MD, Daniel Magoon, Patrick Brown, MD

Blood (2013) 122 (21): 1295.

https://doi.org/10.1182/blood.V122.21.1295.1295

Published: 2013

Journal Articles

Prospective Comparison of Sperm Parameters in SCD Adult Patients Before and after a 6 Months Treatment with hydroxyurea (HU)

Dora Bachir, MD, Francois Lionnet, Justine Gellen Dautremer, Katia Stankovic, Anoosha Habibi, Pablo Bartolucci, MD, PhD, Céline Chalas, Isabelle Berthaut, Florence Eustache, Célia Ravel, Jean Marie Kuntsman, Robert Girot, MD, Tabassome Simon, Jacqueline Mandelbaum, Frederic Galacteros, MD PhD

Blood (2012) 120 (21): 242.

https://doi.org/10.1182/blood.V120.21.242.242

Published: 2012

Journal Articles

A Randomized, Double-Blind, Placebo-Controlled Phase II Trial on the Efficacy, Safety and Tolerability of E5501 (AKR501) In Subjects with Chronic Immune Thrombocytopenia (ITP)

James B. Bussel, MD, Jenny Zhang, Shande Tang, Joe McIntosh, David J. Kuter, MD, DPhil

Blood (2010) 116 (21): 71.

https://doi.org/10.1182/blood.V116.21.71.71

Published: 2010

Journal Articles

Long-Term Efficacy and Safety of Romiplostim Treatment of Adult Patients with Chronic Immune Thrombocytopenia (ITP): Final Report from an Open-Label Extension Study

David J. Kuter, MD, DPhil, James B. Bussel, MD, Adrian Newland, FRCP, Jeffrey S. Wasser, MD, Roger M Lyons, MD, James N. George, MD, Gail Macik, MD, Kun Nie, Susie Jun

Blood (2010) 116 (21): 68.

https://doi.org/10.1182/blood.V116.21.68.68

Published: 2010

Journal Articles

CASPALLO: Phase I Clinical Trial of Allodepleted T Cells Transduced with Inducible Caspase 9 Suicide Gene After Haploidentical Stem Cell Transplantation

Blood (2010) 116 (21): 559.

https://doi.org/10.1182/blood.V116.21.559.559

Published: 2010

Journal Articles

Severe Lenalidomide-Induced Hypersensitivity Pneumonitis

Irene A. Dy, M.D., Eric O. Gamboa, MD, Etta Frankel, M.D.

Blood (2010) 116 (21): 4982.

https://doi.org/10.1182/blood.V116.21.4982.4982

Published: 2010

Journal Articles

Effect of Short-Term Abstinence on Cocaine-Induced Endothelial Dysfunction and Platelet Activation

Jaime Pereira, MD, Claudia G Saez, Ph.D., Julio Pallavicini, M.D., Paulina Olivares, PhD, Natalia Moreno, PhD, Manuel Cabreras, Teresa Massardo, M.D., Diego Mezzano, MD

Blood (2010) 116 (21): 4205.

https://doi.org/10.1182/blood.V116.21.4205.4205

Published: 2010

NARROW

Clinicopathological Analysis of "Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders" Reveals a Favorable Outcome Independent of the Effectiveness of Methotrexate Discontinuation in Autoimmune Disease Patients

Inflammatory Bowel Disease and Hodgkin's Lymphoma: Two New Observations

Interferon May Help Control the Recurrence of Chronic Myeloid Leukemia after Discontinuation of Tyrosine Kinase Inhibitor

Maximum Tolerated Dose (MTD) and Safety Profile from Phase I Study of MT-3724 (CD20 targeted immunotoxin) in Relapsed/Refractory (R/R) Non-Hodgkin B-Cell Lymphoma (NHL)

Acetaminophen Caused Transfusion Dependent Children Repeated Hepatitis

Long-Term Maintenance of Platelet Responses in Adult Patients with Persistent/Chronic Immune Thrombocytopenia Treated with Fostamatinib: 1-Year Efficacy and Safety Results

Avatrombopag, a Novel Oral Thrombopoietin Receptor Agonist, Demonstrates Superiority to Placebo for the Treatment of Chronic Immune Thrombocytopenic Purpura in a Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

A Novel Dual Class III/Src Family Tyrosine Kinase Inhibitor Is Highly Active Against FLT3-ITD Leukemia Cells In Vivo

Observational Study of Magnetic Resonance Imaging Monitoring in Patients with Aplastic Anemia (AA) and Low or Int-1 Risk of Myelodysplastic Syndromes(MDS) Complicated with Iron Overload

Data from the First CD20-Targeted Immunotoxin, MT-3724, in a Phase I/Ib Study in Relapsed/Refractory (R/R) Non-Hodgkin's B-Cell Lymphoma (NHL)

Thrombotic Microangiopathy in Multiple Myeloma

Pulmonary Hypertension (PHT) and Pleural Effusion During Dasatinib Therapy For CML Frequently Lead To Drug Withdrawal

Quality of Life Post Hematopoietic Stem Cell Transplantation for Pediatric Acute Leukemia in Mainland China

Extended Exposure To The CXCR4 Inhibitor Plerixafor May Lead To Enhanced Microenvironment Interactions in Acute Lymphoblastic Leukemia (ALL)

Prospective Comparison of Sperm Parameters in SCD Adult Patients Before and after a 6 Months Treatment with hydroxyurea (HU)

A Randomized, Double-Blind, Placebo-Controlled Phase II Trial on the Efficacy, Safety and Tolerability of E5501 (AKR501) In Subjects with Chronic Immune Thrombocytopenia (ITP)

Long-Term Efficacy and Safety of Romiplostim Treatment of Adult Patients with Chronic Immune Thrombocytopenia (ITP): Final Report from an Open-Label Extension Study

CASPALLO: Phase I Clinical Trial of Allodepleted T Cells Transduced with Inducible Caspase 9 Suicide Gene After Haploidentical Stem Cell Transplantation

Severe Lenalidomide-Induced Hypersensitivity Pneumonitis

Effect of Short-Term Abstinence on Cocaine-Induced Endothelial Dysfunction and Platelet Activation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only